Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Tax Provisions: 2018-2024

Historic Tax Provisions for Puma Biotechnology (PBYI) over the last 7 years, with Dec 2024 value amounting to $897,000.

  • Puma Biotechnology's Tax Provisions rose 37.11% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 29.12%. This contributed to the annual value of $897,000 for FY2024, which is 17.17% down from last year.
  • As of FY2024, Puma Biotechnology's Tax Provisions stood at $897,000, which was down 17.17% from $1.1 million recorded in FY2023.
  • Puma Biotechnology's Tax Provisions' 5-year high stood at $1.1 million during FY2023, with a 5-year trough of $207,000 in FY2020.
  • In the last 3 years, Puma Biotechnology's Tax Provisions had a median value of $897,000 in 2024 and averaged $811,667.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 290.57% in 2020, then dropped by 17.17% in 2024.
  • Puma Biotechnology's Tax Provisions (Yearly) stood at $207,000 in 2020, then soared by 56.52% to $324,000 in 2021, then spiked by 40.43% to $455,000 in 2022, then skyrocketed by 138.02% to $1.1 million in 2023, then declined by 17.17% to $897,000 in 2024.